APTA fundamentals

Aptahem AB is a biotechnology company, which engages in developing drug candidates for the treatment and prevention of disease caused by blockages in blood vessels as the result of blood clots, such as deep vein thrombosis, stroke and heart failure. Its main business model is to clinically develop aptamer-based treatments for life-threatening acute conditions where coagulation and inflammation interact in the disease process. The company was founded by Luiza Jedlina, Bert Junno, Tina Persson, Mikael Lindstam and Johan Lindh in 2014 and is headquartered in Malmo, Sweden.